Management of Uterine Arteriovenous Malformation: Uterine Artery Embolization followed by Gonadotropin-Releasing Hormone Agonist

被引：1
|
作者：
Li, He [1 ]
Yi, Xiaofang [2 ,3 ]
机构：
[1] Fudan Univ, Obstet & Gynecol Hosp, Shanghai Ji Ai Genet & IVF Inst, Shanghai, Peoples R China
[2] Fudan Univ, Dept Gynecol Obstet & Gynecol Hosp, Dept Obstet & Gynecol, Shanghai Med Sch, Shanghai, Peoples R China
[3] Fudan Univ, Shanghai Key Lab Female Reprod Endocrine Related, Shanghai, Peoples R China
来源：
JOURNAL OF MINIMALLY INVASIVE GYNECOLOGY | 2021年 / 28卷 / 05期
关键词：
LAPAROSCOPIC BIPOLAR COAGULATION;
D O I：
10.1016/j.jmig.2020.12.033
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
[No abstract available]
引用
收藏
页码：936 / 937
页数：2
相关论文
共 50 条
  • [31] Effects of gonadotropin-releasing hormone agonists on uterine leiomyomas - Reply
    Kalir, T
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 1998, 122 (12) : 1046 - 1046
  • [32] A Fertility-Preserving Laparoscopic Management Combined With Hysteroscopy of Uterine Arteriovenous Malformation Followed by Uterine Arteries Embolization: A Case Report
    Ouyang, Jing
    Wei, Xia
    Yang, Siqin
    Shi, Yiru
    Hu, Shiqing
    Zhang, Jian
    INTERNATIONAL JOURNAL OF WOMENS HEALTH AND REPRODUCTION SCIENCES, 2019, 7 (04): : 531 - 534
  • [33] Uterine artery embolization for uterine arteriovenous malformation in five women desiring fertility: pregnancy outcomes
    Vilos, Angelos G.
    Vilos, George A.
    Hollett-Caines, Jackie
    Rajakumar, Chandrew
    Garvin, Greg
    Kozak, Roman
    HUMAN REPRODUCTION, 2015, 30 (07) : 1599 - 1605
  • [34] Fertility and pregnancy outcomes following uterine artery embolization (UAE) for uterine arteriovenous malformation (AVM)
    Vilos, Angelos G.
    Vilos, George A.
    de Vrijer, Barbara
    Kozak, Roman
    Abu-Rafea, Basim
    GYNECOLOGICAL SURGERY, 2010, 7 (04) : 401 - 405
  • [35] Laparoscopic Uterine Artery Ligation for Uterine Arteriovenous Malformation
    Bettaiah, Ramesh
    Kamath, Shwetha S.
    JOURNAL OF MINIMALLY INVASIVE GYNECOLOGY, 2018, 25 (07) : 1124 - 1125
  • [36] Concomitant treatment of severe uterine adenomyosis in a premenopausal woman with an aromatase inhibitor and a gonadotropin-releasing hormone agonist
    Kimura, Fuminori
    Takahashi, Kentaro
    Takebayashi, Koichi
    Fujiwara, Mutsuko
    Kita, Nobuyuki
    Noda, Yoichi
    Harada, Nobuhiro
    FERTILITY AND STERILITY, 2007, 87 (06) : 1468.e9 - 1468.e12
  • [37] Suppression of cell proliferation and induction of apoptosis in uterine leiomyoma by gonadotropin-releasing hormone agonist (Leuprolide acetate)
    Mizutani, T
    Sugihara, A
    Nakamuro, K
    Terada, N
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (04): : 1253 - 1255
  • [38] Enhanced polyadenosine diphosphate-ribosylation in gonadotropin-releasing hormone agonist-treated uterine leiomyoma
    Huang, SC
    Tang, MJ
    Cheng, YM
    Hsu, KF
    Ho, CL
    Chou, CY
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (10): : 5009 - 5016
  • [39] Treatment of Urinary Retention Caused by Uterine Leiomyoma With a Gonadotropin-Releasing Hormone Agonist: Case Report and Review
    Chu, Christine M.
    Dabney, Lisa
    Hardart, Anne
    FEMALE PELVIC MEDICINE AND RECONSTRUCTIVE SURGERY, 2013, 19 (01): : 52 - 55
  • [40] The Impact of Preoperative Gonadotropin-Releasing Hormone Agonist Treatment on Women With Uterine Fibroids: A Meta-analysis
    Zhang, Ying
    Sun, Li
    Guo, Yinshu
    Cheng, Jiumei
    Wang, Yongjun
    Fan, Shuying
    Duan, Hua
    OBSTETRICAL & GYNECOLOGICAL SURVEY, 2014, 69 (02) : 100 - 108
12345